- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04185844
American Indian Chronic Renal Insufficiency Cohort Study (AI-CRIC Study) (AI-CRIC)
Study Overview
Status
Detailed Description
Investigators will conduct a longitudinal study of a CKD cohort of Southwest AIs to identify unique risk factors for CKD and CVD progression and compare CKD and CVD event rates and risk factors between AI and the populations represented in CRIC. Investigators will establish a specimen bank to support future ancillary studies designed to identify and examine biomarkers associated with the progression of CKD in AIs.
At the Clinic Visit the following will occur:
- weight is measured
- blood pressure and heart rate are recorded
- information about medical history and medication used recently
- blood draw (about ½ cup) for the following tests: CBC (Complete Blood Count), tests of metabolism, and several other heart and kidney tests
- blood pressure in the leg and arm calculated as the Ankle Brachial Index (ABI)
- urine sample collection for kidney function testing
- complete questionnaires about quality of life, diet, mood, thought processes and physical activity.
This visit takes about 1 to 2 hours. Participants will be contacted by telephone six months after the Baseline Visit to ask about recent medical events and medications.
Participants will be asked to return to the center for annual visits during which many but not all of the procedures described above will be conducted.
Additionally, participants will be asked to participate in one of two substudies using remote data collection techniques to identify trajectories of kidney function and cardiovascular risk sub-phenotypes
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Mark L Unruh, MD
- Phone Number: 505-272-8300
- Email: MLUnruh@salud.unm.edu
Study Locations
-
-
Arizona
-
Phoenix, Arizona, United States, 85016
- Not yet recruiting
- NIDDK-Phoenix Epidemiology and Clinical Research
-
-
New Mexico
-
Albuquerque, New Mexico, United States, 87108
- Recruiting
- First Nations Community Health Source
-
Black Rock, New Mexico, United States, 87327
- Recruiting
- Zuni Health Initiative Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Glomerular Filtration Rate (GFR): eGFR of =>61<80 and microalbuminuria > 30 or eGRF of =<60 (no microalbuminuria required).
Exclusion Criteria:
- Unable or unwilling to provide informed consent
- life expectancy <3 years;
- institutionalized subjects;
- End stage renal disease or renal transplant;
- renal cancer;
- myeloma;
- immunosuppression;
- Polycystic kidney disease;
- participation in any clinical trial,
- current pregnancy
- current incarceration.
- Appears unlikely or unable to participate in the required study procedures as assessed by the investigator, study coordinator or designee.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Slope of the GFR
Time Frame: 5 years
|
Primary outcomes regarding Cardio vascular disease will focus on clinical events indicative of ischemic heart disease, CHF, stroke, and peripheral vascular disease supplemented by radiographic evidence of progressive CVD.
|
5 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Onset of End Stage Renal Disease
Time Frame: 5 years
|
The measure is reflected in decline of GFR levels
|
5 years
|
Significant loss of renal function
Time Frame: 5 years
|
The measure is reflected in decline of GFR levels
|
5 years
|
Composite clinical outcome defined by the occurrence of either 50% decline, or 25 l/min/1.73 m2 decline in GFR from baseline, or onset of ESRD
Time Frame: 5 years
|
The composite clinical outcome includes onset of End Stage Renal Disease, Significant loss of renal function or changes in proteinuria over time from baseline
|
5 years
|
Slope of change in proteinuria over time
Time Frame: 5 years
|
The changes in the levels of proteinuria overtime
|
5 years
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Mark L Unruh, MD, University of New Mexico
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Urologic Diseases
- Disease Attributes
- Chronic Disease
- Female Urogenital Diseases
- Female Urogenital Diseases and Pregnancy Complications
- Urogenital Diseases
- Male Urogenital Diseases
- Heart Diseases
- Cardiovascular Diseases
- Kidney Diseases
- Renal Insufficiency, Chronic
- Renal Insufficiency
Other Study ID Numbers
- 19-159
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Diseases
-
Baker Heart and Diabetes InstitutePrincess Alexandra Hospital, Brisbane, Australia; Royal Perth Hospital; Alice... and other collaboratorsRecruitingHeart Failure | Valve Heart DiseaseAustralia
-
Medical University of ViennaUnknownHeart Diseases | Heart Failure | Valvular Heart DiseaseAustria
-
Centre Chirurgical Marie LannelongueActive, not recruitingValvular Heart Disease | Valve Disease, Heart
-
Abiomed Inc.RecruitingHeart Diseases | Acute Decompensated Heart Failure | Congestive Heart Failure | Acute Heart FailureUnited States
-
Wuerzburg University HospitalRecruitingHeart Failure | Chronic Heart Failure | Chronic Heart DiseaseGermany
-
Aristotle University Of ThessalonikiRecruitingCardiovascular Diseases | Heart Failure | Valvular Heart Disease | Biochemical DysfunctionGreece
-
Kathirvel SubramaniamUniversity of Maryland, Baltimore; CSL BehringRecruitingHeart Failure,Congestive | Heart Disease End StageUnited States
-
University of MichiganTerminatedDiastolic Heart Failure | Hypertensive Heart DiseaseUnited States
-
Wake Forest UniversityNational Institute on Aging (NIA)CompletedHeart Failure, Congestive | Diastolic Heart FailureUnited States
-
University College, LondonBritish Heart Foundation; Horizon 2020 - European CommissionRecruitingValvular Heart DiseaseUnited Kingdom